140 related articles for article (PubMed ID: 36289665)
1. High Quality Performance of Novel Immunoassays for the Sensitive Quantification of Soluble PD-1, PD-L1 and PD-L2 in Blood.
Krueger K; Mayer Z; Gerckens M; Boeck S; Luppa P; Holdenrieder S
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289665
[TBL] [Abstract][Full Text] [Related]
2. Robust Preanalytical Performance of Soluble PD-1, PD-L1 and PD-L2 Assessed by Sensitive ELISAs in Blood.
Krueger K; Mayer Z; Kottmaier M; Gerckens M; Boeck S; Luppa P; Holdenrieder S
Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289796
[TBL] [Abstract][Full Text] [Related]
3. Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies.
Mortensen JB; Monrad I; Enemark MB; Ludvigsen M; Kamper P; Bjerre M; d'Amore F
Eur J Haematol; 2021 Jul; 107(1):81-91. PubMed ID: 33721375
[TBL] [Abstract][Full Text] [Related]
4. The Controversial Role of PD-1 and Its Ligands in Gynecological Malignancies.
Marinelli O; Annibali D; Aguzzi C; Tuyaerts S; Amant F; Morelli MB; Santoni G; Amantini C; Maggi F; Nabissi M
Front Oncol; 2019; 9():1073. PubMed ID: 31681606
[TBL] [Abstract][Full Text] [Related]
5. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis].
Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637
[No Abstract] [Full Text] [Related]
6. The role of PD-1/PD-Ls in the pathogenesis of IgG4-related disease.
Zhang X; Lu H; Peng L; Zhou J; Wang M; Li J; Liu Z; Zhang W; Zhao Y; Zeng X; Lu L
Rheumatology (Oxford); 2022 Feb; 61(2):815-825. PubMed ID: 33930105
[TBL] [Abstract][Full Text] [Related]
7. Clinical Value of the PD-1/PD-L1/PD-L2 Pathway in Patients Suffering from Endometriosis.
Suszczyk D; Skiba W; Zardzewiały W; Pawłowska A; Włodarczyk K; Polak G; Tarkowski R; Wertel I
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232911
[TBL] [Abstract][Full Text] [Related]
8. The concentration of programmed cell death-ligand 1 in the peripheral blood is a useful biomarker for esophageal squamous cell carcinoma.
Akutsu Y; Murakami K; Kano M; Toyozumi T; Matsumoto Y; Takahashi M; Otsuka R; Sekino N; Yokoyama M; Shiraishi T; Matsubara H
Esophagus; 2018 Apr; 15(2):103-108. PubMed ID: 29892935
[TBL] [Abstract][Full Text] [Related]
9. Novel ultrasensitive automated kinetic exclusion assay for measurement of plasma levels of soluble PD-L1, the predictive and prognostic biomarker in cancer patients treated with immune checkpoint inhibitors.
Darwish IA; Alahmad W; Vinoth R
Heliyon; 2024 May; 10(10):e31317. PubMed ID: 38803937
[TBL] [Abstract][Full Text] [Related]
10. Serum Soluble PD-L1, PD-L2, and B7-H5 as Potential Diagnostic Biomarkers of Human Pancreatic Cancer.
Wu W; Xia X; Cheng C; Niu L; Wu J; Qian Y
Clin Lab; 2021 Jun; 67(6):. PubMed ID: 34107622
[TBL] [Abstract][Full Text] [Related]
11. A Tumor-Specific Super-Enhancer Drives Immune Evasion by Guiding Synchronous Expression of PD-L1 and PD-L2.
Xu Y; Wu Y; Zhang S; Ma P; Jin X; Wang Z; Yao M; Zhang E; Tao B; Qin Y; Chen H; Liu A; Chen M; Xiao M; Lu C; Mao R; Fan Y
Cell Rep; 2019 Dec; 29(11):3435-3447.e4. PubMed ID: 31825827
[TBL] [Abstract][Full Text] [Related]
12. Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles.
Menke J; Lucas JA; Zeller GC; Keir ME; Huang XR; Tsuboi N; Mayadas TN; Lan HY; Sharpe AH; Kelley VR
J Immunol; 2007 Dec; 179(11):7466-77. PubMed ID: 18025191
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.
Ghiotto M; Gauthier L; Serriari N; Pastor S; Truneh A; Nunès JA; Olive D
Int Immunol; 2010 Aug; 22(8):651-60. PubMed ID: 20587542
[TBL] [Abstract][Full Text] [Related]
14. Development and Analytical Validation of a Reverse Transcription Droplet Digital PCR (RT-ddPCR) Assay for PD-L1 Transcripts in Circulating Tumor Cells.
Strati A; Zavridou M; Economopoulou P; Gkolfinopoulos S; Psyrri A; Lianidou E
Clin Chem; 2021 Mar; 67(4):642-652. PubMed ID: 33421061
[TBL] [Abstract][Full Text] [Related]
15. PD-L1 gene polymorphisms and low serum level of PD-L1 protein are associated to type 1 diabetes in Chile.
Pizarro C; García-Díaz DF; Codner E; Salas-Pérez F; Carrasco E; Pérez-Bravo F
Diabetes Metab Res Rev; 2014 Nov; 30(8):761-6. PubMed ID: 24816853
[TBL] [Abstract][Full Text] [Related]
16. B7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function.
Ruffner MA; Kim SH; Bianco NR; Francisco LM; Sharpe AH; Robbins PD
Eur J Immunol; 2009 Nov; 39(11):3084-90. PubMed ID: 19757438
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of PD-L2 expression in patients with oral squamous cell carcinoma-A comparison to the PD-L1 expression profile.
Weber M; Wehrhan F; Baran C; Agaimy A; Büttner-Herold M; Kesting M; Ries J
Cancer Med; 2019 Mar; 8(3):1124-1134. PubMed ID: 30659749
[TBL] [Abstract][Full Text] [Related]
18. The generation of PD-L1 and PD-L2 in cancer cells: From nuclear chromatin reorganization to extracellular presentation.
Fan Z; Wu C; Chen M; Jiang Y; Wu Y; Mao R; Fan Y
Acta Pharm Sin B; 2022 Mar; 12(3):1041-1053. PubMed ID: 35530130
[TBL] [Abstract][Full Text] [Related]
19. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
[TBL] [Abstract][Full Text] [Related]
20. Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRNAs Measured Using Closed-System Quantitative Real-Time Polymerase Chain Reaction Are Associated With Outcome and High Negative Predictive Value in Immunotherapy-Treated NSCLC.
Fernandez AI; Gavrielatou N; McCann L; Shafi S; Moutafi MK; Martinez-Morilla S; Vathiotis IA; Aung TN; Yaghoobi V; Bai Y; Chan YG; Weidler J; Herbst R; Bates M; Rimm DL
J Thorac Oncol; 2022 Sep; 17(9):1078-1085. PubMed ID: 35764237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
